Category: Published Articles
-

Tacrolimus Formulations in Renal Transplant Recipients Which One is More Effectiv
Introduction Tacrolimus is a crucial immunosuppressant used to prevent organ rejection in renal transplant recipients. However, maintaining therapeutic levels is challenging due to individual patient variations. A recent study compared three tacrolimus formulations—Immediate-Release (TAC-IR), Extended-Release Capsules (TAC-XL), and Extended-Release Tablets (TAC-XR)—to evaluate their effectiveness in keeping drug levels within the therapeutic range (TTR). Visit Horizon…
-

Plasma Therapy in aHUS Patient with SARS CoV Infection from Journal of Clinical Nephrology
Introduction Atypical Hemolytic Uremic Syndrome (aHUS) is a rare but severe condition that affects the complement system, leading to thrombotic microangiopathy and potential organ damage. Given the complexities of managing aHUS during a SARS-CoV-2 infection, this case study explores the successful use of convalescent plasma therapy in a patient with aHUS and COVID-19. Visit HSPIOA…
-

Dialysis Program on Renal Treatment Modalities Choice from the Journal of Clinical Nephrolog
Introduction In Portugal, approximately 2,500 patients with end-stage chronic kidney disease (CKD stage 5) begin renal replacement therapy (RRT) each year. The choice between kidney transplantation (TX), hemodialysis (HD), peritoneal dialysis (PD), or conservative treatment (CT) is complex, impacting quality of life and long-term health outcomes. A recent study published in the Journal of Clinical…
-

Diffuse Alveolar Hemorrhage A Rare but Serious Complication of Systemic Lupus Erythematosus
Introduction Diffuse Alveolar Hemorrhage (DAH) is a severe yet uncommon manifestation of Systemic Lupus Erythematosus (SLE), presenting a significant challenge in patient management. While pulmonary involvement in SLE is well-documented, DAH remains a rare complication, occurring in only 1% to 5.4% of lupus cases. Early diagnosis and aggressive treatment are crucial for survival. This article…
-

COVID-19 and Rhabdomyolysis Unveiling a Rare but Serious Complication
Introduction: COVID-19 has been widely studied for its impact on the respiratory system, but emerging research suggests that the virus can also lead to severe muscle damage, a condition known as rhabdomyolysis. This rare yet serious complication can result in acute kidney injury (AKI) and other systemic effects, necessitating timely recognition and management. Visit Journal…
